Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference

Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference

PR Newswire

BRIDGEWATER, NJ,, May 17, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the H.C. Wainwright Annual Global Life Sciences Conference.

The fireside chat will become available for on-demand viewing on May 24, 2022 at 7:00 a.m. ET and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the presentation date.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
[email protected]

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
[email protected]

(PRNewsfoto/Insmed Incorporated)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-hc-wainwright-annual-global-life-sciences-conference-301548445.html

SOURCE Insmed Incorporated

Copyright CNW Group 2022